Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,504,530
-$445,258 QoQ
Shares Held
145,537
+3.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#746
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProVise Management Group, LLC holds $49,564,821 across 10 Drug Manufacturers - General names. PFE ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
134,100 | $21,016,152 | |
| 2 | GSK |
GSK plc
|
123,527 | $6,475,285 | |
| 3 | AMGN |
Amgen Inc
|
16,496 | $5,973,531 | |
| 4 | SNY |
Sanofi
|
120,829 | $5,154,565 | |
| 5 | PFE |
Pfizer Inc
This page
|
145,537 | $3,504,530 | |
| 6 | ABBV |
AbbVie Inc.
|
10,735 | $2,701,355 | |
| 7 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 8 | JNJ |
Johnson & Johnson
|
6,573 | $1,669,344 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,504,530 | 145,537 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,949,788 | 140,662 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,379,428 | 135,720 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,321,802 | 130,369 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,221,035 | 132,881 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,892,738 | 114,157 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,834,199 | 106,830 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,774,123 | 130,412 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,607,349 | 128,926 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,518,561 | 126,795 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,756,490 | 130,479 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,497,686 | 135,595 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,833,250 | 131,768 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $5,248,267 | 128,634 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $12,332,955 | 240,690 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $10,809,595 | 247,020 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $12,791,609 | 243,975 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $12,497,070 | 241,396 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $14,124,287 | 239,192 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $10,257,798 | 238,498 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $9,164,262 | 234,021 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $8,313,154 | 229,455 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $8,357,047 | 227,032 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $8,200,643 | 223,451 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $7,313,460 | 223,653 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $7,527,622 | 230,626 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||